Arkolith/Insider Trading/LYRA/Form 4

Merrifield C Ann

DirectorLyra Therapeutics, Inc. (LYRA) · full profile →Form 4 · filed May 17, 2022
Net Buying
Open-Market Buys
$18K
Open-Market Sells
$0
Net Open-Market Flow
$18K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 16, 2022Buy(P)328$5.00$2K7K
May 13, 2022Buy(P)4K$4.81$17K7K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-22-018435) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML